Lower blood glucose and variability are associated with earlier recovery from renal injury caused by episodic urinary tract infection in advanced type 2 diabetic chronic kidney disease

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Chiu, Ping Fang ^a,b   Wu, Chia Lin ^b   Huang, Ching Hui ^b   Liou, Hung Hsiang ^b   Chang, Chirn Bin ^b   Chang, Horng Rong ^a,c   Chang, Chia Chu ^a,b,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ANTIINFECTIVE AGENT; GLUCOSE BLOOD LEVEL;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; URINARY TRACT INFECTION; BLOOD; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

AGED; ANTI-BACTERIAL AGENTS; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; FASTING; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84907447732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108531     Document Type: Article

References (35)

1. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, et al. (2005) Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus. Clin Infect Dis 41: 281-288.
2. Balachandar MS, Pavković P, Metelko Ž (2002) Kidney infections in diabetes mellitus. Diabetologia Croatica 31: 85-103.
3. Nicolle LE, Friesen D, Harding GK, Roos LL (1996) Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis 22: 1051-1056.
4. Robbins SL, Tucker AW (1944) The cause of death in diabetes. A report of 307 autopsied cases. N Engl J Med 231: 865-868.
5. Chiu PF, Huang CH, Liou HH, Wu CL, Wang SC, et al. (2013) Long-term renal outcomes of episodic urinary tract infection in diabetic patients. J Diabetes Complications 27: 41-43.
6. Thakar CV, Christianson A, Himmelfarb J, Leonard AC (2011) Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 6: 2567-2572.
7. Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A (2011) Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med 37: 583-593.
8. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 355: 806-808.
9. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 30: 2205-2211.
10. Luckraz H, Gravenor MB, George R, Taylor S, Williams A, et al. (2005) Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass. Eur J Cardiothorac Surg 27: 906-909.
11. Zhang Y, Hu G, Yuan Z, Chen L (2012) Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One 7: e42551. doi: 10.1371/journal.pone.0042551.
12. Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, et al. (2008) Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 34: 612-616.
13. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, et al. (2011) Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 34: 1605-1609.
14. Monnier L, Colette C, Owens DR 2008) Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2: 1094-1100.
15. Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A (2011) Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med 37: 583-593.
16. Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36: 3008-3013.
17. Jeon CY, Furuya EY, Berman MF, Larson EL (2012) The role of pre-operative and post-operative glucose control in surgical-site infections and mortality. PLoS One 7: e45616. doi: 10.1371/journal.pone.0045616.
18. Pisarchik AN, Pochepen ON, Pisarchyk LA (2012) Increasing blood glucose variability is a precursor of sepsis and mortality in burned patients. PLoS One 7: e46582. doi: 10.1371/journal.pone.0046582
19. Haga KK, McClymont KL, Clarke S, Grounds RS, Ng KY, et al. (2011) The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis. J Cardiothorac Surg 6: 3. Available: http://www.cardiothoracicsurgery.org/content/6/1/3. Accessed 2011 Jan 10.
20. Siegelaar SE, Kerr L, Jacober SJ, Devries JH (2011) A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction. Diabetes Care 34: 855-857.
21. Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults. JAMA 8: 933-944.
22. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, et al. (2009) Intensive insulin therapy and mortality among critically ill patients: a metaanalysis including NICE-SUGAR study data. CMAJ 8: 821-827.
23. Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283-1297.
24. American Diabetes Association (2013) Standards of medical care in Diabetes-2013. Diabetes Care 36: S11-S66
25. Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, et al. (2012) Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function. Diabetes Care 35: 817-820.
26. Chiodini I, Di Lembo S, Morelli V, Epaminonda P, Coletti F, et al. (2006) Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance. Metabolism 55: 1135-1140.
27. Tsigos C, Young RJ, White A (1993) Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 76: 554-558.
28. Monnier L, Mas E, Ginet C, Michel F, Villon L, et al. (2006) Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes. JAMA 295:1681-1687
29. Rizzo MR, Barbieri M, Marfella R, Paolisso G (2012) Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 35: 2076-2082.
30. Bochicchio GV, Bochicchio KM, Joshi M, Ilahi O, Scalea TM (2010) Acute glucose elevation is highly predictive of infection and outcome in critically injured trauma patients. Ann Surg 252: 597-602.
31. Tudela P, Prat C, Lacoma A, Mòdol Deltell JM, Domínguez J, et al. (2012) Biological markers for predicting bacterial infection, bacteremia, and severity of infection in the emergency department. Emergencias 24: 348-356
32. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM (2011) Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 135: 182-189
33. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, et al. (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638-1652.
34. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH (2010) Glucose variability; does it matter? Endocr Rev 31: 171-182.
35. Rodbard D (2012) The challenges of measuring glycemic variability. J Diabetes Sci Technol 6: 712-715.